X0609 4 2026-03-27 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001644087 Donovan Joanne M. false C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 false true false false CMO true Common Stock 2026-03-27 4 S false 9623.00 30.9778 D 16332.00 D Common Stock 2026-03-27 4 S false 6735.00 30.9778 D 9597.00 D The shares sold were acquired through multiple purchases under the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan on May 15, 2022 (1,392 shares), November 15, 2022 (1,406 shares), May 15, 2023 (1,451 shares), November 15, 2023 (1,751 shares), May 15, 2024 (1,803 shares), and November 15, 2024 (1,820 shares). The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.49 to $31.68, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 594 shares purchased on November 17,2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. John R. Moore Attorney-in-Fact for Donovan Joanne M. 2026-03-30